SLNSW-Head-to-head, randomised, crossover study of oral...-TN_cdi_proquest_journals_1777903370

Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses ≥15 mg may be overcome with subcutaneous administration

Full title: Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses ≥15 mg may be overcome with subcutaneous administration

Author/creator: Schiff, Michael H, Jaffe, Jonathan S, Freundlich, Bruce.

Call Numbers:

Record Identifier: TN_cdi_proquest_journals_1777903370

Language: English

Formats: Articles

Publishers: England: BMJ Publishing Group Ltd

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1777903370

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses ≥15 mg may be overcome with subcutaneous administration

    Record identifier

    TN_cdi_proquest_journals_1777903370

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1777903370

    Share

    Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses ≥15 mg may be overcome with subcutaneous administration

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1777903370

    Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses ≥15 mg may be overcome with subcutaneous administration

    Full title

    Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses ≥15 mg may be overcome with subcutaneous administration

    Author / Creator

    Schiff, Michael H ; Jaffe, Jonathan S ; Freundlich, Bruce

    Publisher

    England: BMJ Publishing Group Ltd

    Journal title

    Annals of the rheumatic diseases, 2014, Vol.73 (8), p.1549-1551

    Record Identifier

    TN_cdi_proquest_journals_1777903370

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    1506 Administration, Oral Aged Analysis Antirheumatic Agents - administration & dosage Antirheumatic Agents - adverse effects Antirheumatic Agents - pharmacokinetics Arthritis, Rheumatoid - drug therapy Bioavailability Care and treatment Clinical and Epidemiological Research Clinical medicine Cross-Over Studies Diagnosis Dose-Response Relationship, Drug Drug Administration Routes Drug dosages Female Humans Injections, Subcutaneous Male Methods Methotrexate Methotrexate - administration & dosage Methotrexate - adverse effects Methotrexate - pharmacokinetics Middle Aged Pharmacokinetics Rheumatoid Arthritis Self Administration - instrumentation Variance analysis

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_proquest_journals_1777903370

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1777903370

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections